Literature DB >> 18489049

Discordant response to rituximab in a systemic sclerosis patient with associated myositis.

Mario Fabri, Nicolas Hunzelmann, Thomas Krieg, Andrea Rubbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18489049     DOI： 10.1016/j.jaad.2007.06.010

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Efficacy and safety of rituximab in rheumatic diseases.

Authors:  Eva Rath; Jochen Zwerina; Bastian Oppl; Valerie Nell-Duxneuner
Journal:  Wien Med Wochenschr       Date:  2015-01-21

2.  B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis.

Authors:  Jacob M van Laar
Journal:  Arthritis Res Ther       Date:  2010-04-22       Impact factor: 5.156

Review 3.  Is biological therapy in systemic sclerosis the answer?

Authors:  Durga Prasanna Misra; Sakir Ahmed; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2020-01-20       Impact factor: 2.631

Review 4.  [Anti-B-cell strategies in vasculitides and collagenoses].

Authors:  A Rubbert-Roth
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.